BPC-157 may prove useful when human trials are completed, but currently it is a hypothesis with promising animal support, not a proven therapy
A similar reduction of the dynamic range due to amino acid insertion next to Cys147 has already been reported for several roGFP1-iX variants but not for the roGFP1-iL version (Lohman and Remington, in vivo measurements
BPC-157 is a synthetic (lab-made) version of a peptide that was first discovered in substances found in digestive fluid
What do randomized controlled trials of high-dose daily vitamin B12 supplementation show about the effects on cancer risk, death, and longevity
Summers, Anne Thorburn, Esra Ogru, Robert Gianello, Woei-Jia Jiang, Frank M
One missed injection across a 20+ week protocol has minimal impact on overall outcomes